Cargando…

TORCH screening used appropriately in China?─three years results from a teaching hospital in northwest China

OBJECTIVES: TORCH infections caused by Toxoplasma gondii (TOX), rubella virus (RV), cytomegalovirus (CMV) and herpes simplex virus 1,2 (HSV-1,2) are associated with congenital anomalies. The study aimed to analyze the characteristics of TORCH screening in reproductive age women. METHODS: A total of...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Lin-Chuan, Yan, Fang, Ruan, Jing-Xiong, Xiao, Yao, Yu, Yan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6902533/
https://www.ncbi.nlm.nih.gov/pubmed/31818265
http://dx.doi.org/10.1186/s12884-019-2642-7
_version_ 1783477689140641792
author Wang, Lin-Chuan
Yan, Fang
Ruan, Jing-Xiong
Xiao, Yao
Yu, Yan
author_facet Wang, Lin-Chuan
Yan, Fang
Ruan, Jing-Xiong
Xiao, Yao
Yu, Yan
author_sort Wang, Lin-Chuan
collection PubMed
description OBJECTIVES: TORCH infections caused by Toxoplasma gondii (TOX), rubella virus (RV), cytomegalovirus (CMV) and herpes simplex virus 1,2 (HSV-1,2) are associated with congenital anomalies. The study aimed to analyze the characteristics of TORCH screening in reproductive age women. METHODS: A total of 18,104 women (2015–2017) from a teaching hospital in Xi’an, China, were enrolled in the study. The characteristics of TORCH screening, i.e., the application of TORCH test, the seroprevalence, the impact of age, periods of gestation and woman with bad obstetric history (BOH) on the serological data were investigated. RESULTS: In the study, 319 women (1.76%) performed dynamic TORCH test. 51.66, 20.44 and 3.83% of the population did the test in the pre-gestation period, the first and third trimester, respectively. Quite a few pre-gestation women (29.74%) ignored screening of IgG antibodies. The overall IgG/IgM seropositvity of TOX, RV, CMV, HSV-1 and HSV-2 was 4.35%/0.35, 90%/0.63, 96.79%/0.97, 81.11%/0.14 and 6.1%/0.19%, respectively. The age-specific distributions and periods of gestation had no significant effect on the seroprevalence of TORCH agents, p>0.05. However, BOH was significantly associated with higher seropositvity of IgM (RV, CMV, HSV-1 and HSV-2) and IgG (CMV and HSV-1) antibodies, p < 0.05. CONCLUSION: In Xi’an region, more attentions should be paid to TOX, CMV, HSV-2 and the women with BOH for TORCH screening. Meanwhile, a greater emphasis needs to be placed on TORCH test used inappropriately in China.
format Online
Article
Text
id pubmed-6902533
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-69025332019-12-11 TORCH screening used appropriately in China?─three years results from a teaching hospital in northwest China Wang, Lin-Chuan Yan, Fang Ruan, Jing-Xiong Xiao, Yao Yu, Yan BMC Pregnancy Childbirth Research Article OBJECTIVES: TORCH infections caused by Toxoplasma gondii (TOX), rubella virus (RV), cytomegalovirus (CMV) and herpes simplex virus 1,2 (HSV-1,2) are associated with congenital anomalies. The study aimed to analyze the characteristics of TORCH screening in reproductive age women. METHODS: A total of 18,104 women (2015–2017) from a teaching hospital in Xi’an, China, were enrolled in the study. The characteristics of TORCH screening, i.e., the application of TORCH test, the seroprevalence, the impact of age, periods of gestation and woman with bad obstetric history (BOH) on the serological data were investigated. RESULTS: In the study, 319 women (1.76%) performed dynamic TORCH test. 51.66, 20.44 and 3.83% of the population did the test in the pre-gestation period, the first and third trimester, respectively. Quite a few pre-gestation women (29.74%) ignored screening of IgG antibodies. The overall IgG/IgM seropositvity of TOX, RV, CMV, HSV-1 and HSV-2 was 4.35%/0.35, 90%/0.63, 96.79%/0.97, 81.11%/0.14 and 6.1%/0.19%, respectively. The age-specific distributions and periods of gestation had no significant effect on the seroprevalence of TORCH agents, p>0.05. However, BOH was significantly associated with higher seropositvity of IgM (RV, CMV, HSV-1 and HSV-2) and IgG (CMV and HSV-1) antibodies, p < 0.05. CONCLUSION: In Xi’an region, more attentions should be paid to TOX, CMV, HSV-2 and the women with BOH for TORCH screening. Meanwhile, a greater emphasis needs to be placed on TORCH test used inappropriately in China. BioMed Central 2019-12-09 /pmc/articles/PMC6902533/ /pubmed/31818265 http://dx.doi.org/10.1186/s12884-019-2642-7 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Wang, Lin-Chuan
Yan, Fang
Ruan, Jing-Xiong
Xiao, Yao
Yu, Yan
TORCH screening used appropriately in China?─three years results from a teaching hospital in northwest China
title TORCH screening used appropriately in China?─three years results from a teaching hospital in northwest China
title_full TORCH screening used appropriately in China?─three years results from a teaching hospital in northwest China
title_fullStr TORCH screening used appropriately in China?─three years results from a teaching hospital in northwest China
title_full_unstemmed TORCH screening used appropriately in China?─three years results from a teaching hospital in northwest China
title_short TORCH screening used appropriately in China?─three years results from a teaching hospital in northwest China
title_sort torch screening used appropriately in china?─three years results from a teaching hospital in northwest china
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6902533/
https://www.ncbi.nlm.nih.gov/pubmed/31818265
http://dx.doi.org/10.1186/s12884-019-2642-7
work_keys_str_mv AT wanglinchuan torchscreeningusedappropriatelyinchinathreeyearsresultsfromateachinghospitalinnorthwestchina
AT yanfang torchscreeningusedappropriatelyinchinathreeyearsresultsfromateachinghospitalinnorthwestchina
AT ruanjingxiong torchscreeningusedappropriatelyinchinathreeyearsresultsfromateachinghospitalinnorthwestchina
AT xiaoyao torchscreeningusedappropriatelyinchinathreeyearsresultsfromateachinghospitalinnorthwestchina
AT yuyan torchscreeningusedappropriatelyinchinathreeyearsresultsfromateachinghospitalinnorthwestchina